Article: Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy

€3.03

SKU: product-article-44939 Category: General

Description
Reviews (0)

Description

Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy

Reviews

There are no reviews yet.

Be the first to review “Article: Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy”

You must be logged in to post a review.

Top

Article: Teclistamab also effective in patients with relapsed or refractory multiple myeloma who previously received anti-BCMA therapy

Description

Reviews

Related products

Article: Highlights in gynaecological cancers

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: INTRODUCTION

Article: Highlights in respiratory oncology